Amedeo's Top 20

Amedeo Smart

Independent Medical Education

18 September 2023

Multidisciplinary Journal Club

  1. Meaidi A, Mascolo A, Sessa M, Toft-Petersen AP, et al.
    Venous thromboembolism with use of hormonal contraception and non-steroidal anti-inflammatory drugs: nationwide cohort study.
    BMJ 2023;382:e074450.

  1. Del Zotto E, Grassi M, Zedde M, Zini A, et al.
    Risk profile of patients with spontaneous cervical artery dissection.
    Ann Neurol 2023.

  2. Rowan C.
    In moderate-to-severe Crohn disease, upadacitinib increased clinical remission at 12 and 52 wk.
    Ann Intern Med 2023.

  3. Peyrin-Biroulet L, Allegretti JR, Rubin DT, Bressler B, et al.
    Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study.
    Gastroenterology 2023.

  4. Wharton S, Blevins T, Connery L, Rosenstock J, et al.
    Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity.
    N Engl J Med 2023.

  1. Raison CL, Sanacora G, Woolley J, Heinzerling K, et al.
    Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial.
    JAMA 2023;330:843-853.

  2. Kutz A, Kim DH, Wexler DJ, Liu J, et al.
    Comparative Cardiovascular Effectiveness and Safety of SGLT-2 Inhibitors, GLP-1 Receptor Agonists, and DPP-4 Inhibitors According to Frailty in Type 2 Diabetes.
    Diabetes Care 2023.

  3. Kavanagh MM, Wenham C, Massard da Fonseca E, Helfer LR, et al.
    Increasing compliance with international pandemic law: international relations and new global health agreements.
    Lancet 2023.

  4. Roux H, Chomont N.
    Measuring HIV reservoirs: Do we need to choose between quantity and quality?
    J Infect Dis 2023.

  5. Martins Custodio H, Clayton LM, Bellampalli R, Pagni S, et al.
    Widespread genomic influences on phenotype in Dravet syndrome, a 'monogenic' condition.
    Brain 2023;146:3885-3897.

  1. Shoung A, Shoung N, Hii R, Nerlekar N, et al.
    Electrocardiogram Changes Following Intravenous Bisphosphonate Infusion: A Systematic Review and Meta-Analysis.
    J Bone Miner Res 2023.

  2. Gilron I, Robb S, Tu D, Holden RR, et al.
    Randomized, double-blind, controlled trial of a combination of alpha-lipoic acid and pregabalin for neuropathic pain: the PAIN-CARE trial.
    Pain 2023.

  3. Moskowitz A, Berg KM, Grossestreuer AV, Balaji L, et al.
    Thiamine for Renal Protection in Septic Shock (TRPSS): A Randomized, Placebo-controlled, Clinical Trial.
    Am J Respir Crit Care Med 2023;208:570-578.

  4. Maier B, Finitsis S, Mazighi M, Lapergue B, et al.
    Thrombectomy with or without intravenous thrombolytics in basilar artery occlusion.
    Ann Neurol 2023.

  5. O'Donnell HK, Rasmussen CG, Dong F, Simmons KM, et al.
    Anxiety and Risk Perception in Parents of Children Identified by Population Screening as High Risk for Type 1 Diabetes.
    Diabetes Care 2023.

  1. Shumway DA, Corbin KS, Farah MH, Viola KE, et al.
    Partial breast irradiation compared with whole breast irradiation: a systematic review and meta-analysis.
    J Natl Cancer Inst 2023;115:1011-1019.

  2. Auvin S, Galanopoulou AS, Moshe SL, Potschka H, et al.
    Revisiting the concept of drug-resistant epilepsy: A TASK1 report of the ILAE/AES Joint Translational Task Force.
    Epilepsia 2023.

  3. Merdji H, Long MT, Ostermann M, Herridge M, et al.
    Sex and gender differences in intensive care medicine.
    Intensive Care Med 2023.

  4. Gonzales MM, Garbarino VR, Kautz TF, Palavicini JP, et al.
    Senolytic therapy in mild Alzheimer's disease: a phase 1 feasibility trial.
    Nat Med 2023.

  5. Pratz KW, Cherry M, Altman JK, Cooper BW, et al.
    Gilteritinib in Combination With Induction and Consolidation Chemotherapy and as Maintenance Therapy: A Phase IB Study in Patients With Newly Diagnosed AML.
    J Clin Oncol 2023;41:4236-4246.


more..

Privacy Policy